2017
DOI: 10.1016/j.ijheh.2017.06.008
|View full text |Cite
|
Sign up to set email alerts
|

Exposure assessment using human biomonitoring for glyphosate and fluroxypyr users in amenity horticulture

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
46
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 68 publications
(59 citation statements)
references
References 44 publications
4
46
0
Order By: Relevance
“…Critical gaps in the re-registration of glyphosate, including the EU re-registration process itself, have been addressed (European Parliament Council, 2002;Myers et al, 2016), particularly those considered more pressing by recent scientific findings. These include: (a) increasing exposures of EU citizens to glyphosate residues, supported by human and environmental biomonitoring data in limited number (Curwin et al, 2007;Mesnage et al, 2012;Krüger et al, 2014;Niemann et al, 2015;Connolly et al, 2017;Conrad et al, 2017;Mills et al, 2017;Vandenberg et al, 2017), but identifying a clearly rising trend; (b) carcinogenicity classification by IARC, evidence of linkages of glyphosate or its formulated products to non-Hodgkin's lymphoma (Hardell et al, 2002;De Roos et al, 2003Eriksson et al, 2008;Schinasi and Leon, 2014;Mesnage et al, 2015b), and effective dose levels indicated in rodent oncogenicity studies being 1-2 orders of magnitude lower when formulated glyphosate-based herbicides were used compared to those obtained with the pure active ingredient; (c) evidence of contributions to fatal chronic kidney disease by glyphosate in areas with heavy metals in water (Jayasumana et al, 2014(Jayasumana et al, , 2015 and the finding of nonalcoholic fatty liver disease upon exposure to a glyphosatebased herbicide (Roundup R ) (Mesnage et al, 2017b), coupled with the powerful animal metabolism data embedded within the re-registration document appendices (showing glyphosate and AMPA levels higher in kidney than in liver, and much higher than in muscle tissue); as well as (d) problems (e.g., risk assessment studies for regulatory purposes of re-registration of glyphosate being carried out with pure glyphosate) arising from the dual character of pesticide registration in the EU with active ingredients authorized at EU and formulated products at MS level (Klátyik et al, 2017a). In light of these findings, earlier risk assessment statements (Williams et al, 2000) are untenable for both hazard and exposure levels.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Critical gaps in the re-registration of glyphosate, including the EU re-registration process itself, have been addressed (European Parliament Council, 2002;Myers et al, 2016), particularly those considered more pressing by recent scientific findings. These include: (a) increasing exposures of EU citizens to glyphosate residues, supported by human and environmental biomonitoring data in limited number (Curwin et al, 2007;Mesnage et al, 2012;Krüger et al, 2014;Niemann et al, 2015;Connolly et al, 2017;Conrad et al, 2017;Mills et al, 2017;Vandenberg et al, 2017), but identifying a clearly rising trend; (b) carcinogenicity classification by IARC, evidence of linkages of glyphosate or its formulated products to non-Hodgkin's lymphoma (Hardell et al, 2002;De Roos et al, 2003Eriksson et al, 2008;Schinasi and Leon, 2014;Mesnage et al, 2015b), and effective dose levels indicated in rodent oncogenicity studies being 1-2 orders of magnitude lower when formulated glyphosate-based herbicides were used compared to those obtained with the pure active ingredient; (c) evidence of contributions to fatal chronic kidney disease by glyphosate in areas with heavy metals in water (Jayasumana et al, 2014(Jayasumana et al, , 2015 and the finding of nonalcoholic fatty liver disease upon exposure to a glyphosatebased herbicide (Roundup R ) (Mesnage et al, 2017b), coupled with the powerful animal metabolism data embedded within the re-registration document appendices (showing glyphosate and AMPA levels higher in kidney than in liver, and much higher than in muscle tissue); as well as (d) problems (e.g., risk assessment studies for regulatory purposes of re-registration of glyphosate being carried out with pure glyphosate) arising from the dual character of pesticide registration in the EU with active ingredients authorized at EU and formulated products at MS level (Klátyik et al, 2017a). In light of these findings, earlier risk assessment statements (Williams et al, 2000) are untenable for both hazard and exposure levels.…”
Section: Resultsmentioning
confidence: 99%
“…A systematic study carried out in Southern California found that the mean glyphosate and AMPA levels in human urine increased between 1993 and 2016, and reached 0.449 and 0.401 ng/ml, respectively (Mills et al, 2017). It has to be noted that levels of 3.3-73.5 ng/ml have been reported in a non-peer reviewed report in Germany (Connolly et al, 2017).…”
Section: Exposure To Glyphosate-environmental and Food Analysis Humamentioning
confidence: 93%
See 1 more Smart Citation
“…There are few published studies on biomonitoring reports of occupational exposure to GLY, and these are limited to spraying, horticulture and other agricultural aspects [20,[22][23][24]. In this paper, to avoid the influence of preparations, we selected people who were only involved in GLY production (without exposure to its preparations) as our research subjects.…”
Section: Introductionmentioning
confidence: 99%
“…Nowadays, GBHs are the most widely used herbicides in the world (Benbrook 2016;Myers et al 2016) and their use may result in exposure of the general public as well as of applicators (Solomon 2016). Glyphosate was detected in urine samples of farmers (Jayasumana et al 2015), amenity horticulturists (Connolly et al 2017) as well as in samples of the general public (Conrad et al 2017;Connolly et al 2018). In March 2015, glyphosate was classified as a "probable carcinogen for humans" (group 2A) by the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) (Guyton et al 2015).…”
Section: Introductionmentioning
confidence: 99%